Drug Companies Largely Acted Legally Amid Opioid Crisis, Says Law Professor
"The pharmaceutical industry is being scapegoated for something where there's plenty of blame to go around," says Northeastern University's Leo Beletsky.
Where Are States Sending Their Opioid Dollars?
With recent criticism comparing opioid settlements to the tobacco settlements from decades ago—where billions of dollars went unaccounted for—all eyes are on local officials and their burgeoning settlement coffers.
Drug Companies Aren't Apologizing for the Opioid Crisis, Settlements or Not
In nearly a dozen cases reviewed by Newsweek, drug firms that flooded the U.S. with deadly painkillers over the years have clauses in their settlements that absolve them from saying they did anything wrong.
Victims of Opioid Crisis Won't See Any Money From Major Ohio Settlement
"Of course states need to be compensated. But the concern is that very little money actually filters down to those who have been most deeply affected," Kate Nicholson, civil rights attorney and patient advocate, told Newsweek in an interview.
Opioid Crisis Driven by Shady Drug Company Tactics
Investigators are closing in on Big Pharma, claiming that shady tactics fueled the opioid crisis.
Watchdog Sues Administration for Drug Pricing Details
Democracy Forward is suing for details about a former pharmaceutical lobbyist's role in drug regulation.
Rx Won't Address Antibiotic Resistance
We need to flat-out socialize the development of new antibiotics, and increasingly regulate the use of existing ones.
Epipen Controversy Exposes Systemic Healthcare Flaws
The EpiPen affair doesn't expose a broken system—healthcare was designed this way, with profit as the chief concern.
Drug Trial Leaves One Brain-Dead and Five Injured
The clinical trial in western France was of an experimental medicine from an unnamed drug company.
Shkreli Was Caught Doing What Big Pharma Does
While other drugs companies don't raise their drug prices fiftyfold, they would if it led to fat profits.
Should Drug Prices Be Capped?
Government price fixing will produce unintended consequences in drug research and pricing.